Related Experiment Video
Updated: Dec 10, 2025
05:26
Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways
Published on: April 12, 2024
2.2K
[Pharmaceutical aspects of medicated myopia control]
S E Avetisov1,2, V P Fisenko1, A S Zhuravlev1
1I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Vestnik Oftalmologii
|September 4, 2020
Summary
This study reviews drug-induced myopia control methods, analyzing their effectiveness and exploring new options for medicated myopia correction.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Myopia, or nearsightedness, is a growing global health concern.
- Current myopia control strategies have limitations.
Purpose of the Study:
- To analyze the mechanisms of drug-induced myopia control.
- To evaluate the effectiveness of various pharmacological approaches.
- To identify promising options for medicated myopia correction.
Main Methods:
- Literature review of studies on drug-induced myopia control.
- Analysis of data on the efficacy and safety of different pharmacological agents.
- Assessment of novel therapeutic strategies.
Main Results:
- Drug-induced myopia control mechanisms vary among different agents.
- Several pharmacological approaches show potential effectiveness in slowing myopia progression.
- Medicated correction offers promising avenues for myopia management.
Conclusions:
- Drug-induced myopia control is a developing field with significant potential.
- Further research is needed to optimize therapeutic strategies and ensure long-term efficacy and safety.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
864
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
864
01:28Angle Closure Glaucoma: Treatment
996
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
996
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.1K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.1K
01:25Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.4K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.4K
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
91
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
91